Talk:Saturated fat and cardiovascular disease

This redirect was nominated at Wikipedia:Redirects for discussion on 28 August 2023. The result of the discussion was speedy keep.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Saturated fat and cardiovascular disease.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Archives

Archive 1

Unreliable source

The paper [1] was funded by Nina Teicholz's group called "Nutrition Coalition". I have commented over at the saturated fat talk-page about this so have removed my lengthy response here. If anyone wants to discuss that paper best to discuss it over there. Here is the link to the discussion [2] Psychologist Guy (talk) 22:43, 27 June 2021 (UTC)[reply]

Regarding the quote

The AHA when regarding the 2014 meta analysis (16th reference):

"Meta-analyses of prospective observational studies aiming to determine the effects on CVD of saturated fat that did not take into consideration the replacement macronutrient have mistakenly concluded that there was no significant effect of saturated fat intake on CVD risk.15,16"

"We examined several recent systematic reviews and meta-analyses9,10,16 from which we identified and here discuss 4 trials20–22,30 that make up the core evidence on this important question on the basis of quality of study design, execution, and adherence. These trials compared high saturated with high polyunsaturated fat intake but 1. did not include trans unsaturated fat as a major component 2. controlled the dietary intake of the intervention and control groups 3. had at least 2 years of sustained intake of the assigned diets 4. proved adherence by objective biomarkers such as serum cholesterol or blood or tissue levels of polyunsaturated fatty acids and 5. collected and validated information on cardiovascular or coronary disease events. The reason for the 2-year minimum duration is that changes in polyunsaturated fatty acids very slowly equilibrate with tissue fatty acid levels; it takes ≈2 years to achieve 60% to 70% of the full effect.20,30 Trials of serum cholesterol–lowering agents show that a reduction in coronary heart disease (CHD) incidence occurs with a lag of 1 to 2 years.31 These systematic reviews9,10,16 together found and analyzed 6 additional trials7,23,32–35 that replaced saturated with polyunsaturated fat but did not have ≥1 of these characteristics crucial to testing the hypothesis. We also discuss these “noncore” trials and evaluate their potential impact on the overall result on dietary saturated and polyunsaturated fat and risk of CVD."

Would that quote be considered accurate? I use it for the whole 2014 meta analysis but the AHA used it to critique the 2014 review for not considering the replacement macronutrient. RBut (talk) 00:46, 1 July 2021 (UTC)[reply]

Zefr has dealt with this, we now cite a quote from the AHA on that. Psychologist Guy (talk) 20:24, 1 July 2021 (UTC)[reply]

Merge article

This article has gotten smaller and smaller over time because there is so much unreliable content about this subject. As it stands this is basically just duplicated material from the saturated fat article which has a section on Cardiovascular disease. I suggest merging this article into that section on the saturated fat article. I don't think this article serves any purpose. The content could be just included there. Psychologist Guy (talk) 20:24, 1 July 2021 (UTC)[reply]

I second this notion. RBut (talk) 21:17, 1 July 2021 (UTC)[reply]
Support. Zefr (talk) 21:22, 1 July 2021 (UTC)[reply]
Support makes sense per WP:NOPAGE. Seems a bit pov-forkish as-is. Alexbrn (talk) 16:00, 8 July 2021 (UTC)[reply]